Anxo Pharmaceutical Co (ROCO:6677) Ending Cash Position : NT$197.2 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co Ending Cash Position?

Anxo Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2023 was NT$197.2 Mil.

Anxo Pharmaceutical Co's quarterly Ending Cash Position increased from Jun. 2022 (NT$210.3 Mil) to Dec. 2022 (NT$241.3 Mil) but then declined from Dec. 2022 (NT$241.3 Mil) to Jun. 2023 (NT$197.2 Mil).

Anxo Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2020 (NT$207.8 Mil) to Dec. 2021 (NT$214.2 Mil) and increased from Dec. 2021 (NT$214.2 Mil) to Dec. 2022 (NT$241.3 Mil).

Anxo Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Anxo Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co Ending Cash Position Chart

Anxo Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

153.89

177.63

207.76

214.18

241.32

Anxo Pharmaceutical Co Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Ending Cash Position	Get a 7-Day Free Trial												158.00	214.18	210.31	241.32	197.21

Anxo Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Anxo Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	214.184	+	27.139
	=	241.3

Anxo Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	241.323	+	-44.111
	=	197.2

Anxo Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anxo Pharmaceutical Co (ROCO:6677) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN

Website

http://www.anxo.com.tw

Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines